Corrigendum to “Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)”
Emmanuelle Bompas, A. Le Cesne, Emmanuelle Tresch‐Bruneel, Loïc Lebellec, Valérie Laurence, Olivier Collard, Esma Saâda-Bouzid, Nicolás Isambert, Jean Yves Blay, Éric Amela, Sébastien Salas, Christine Chevreau, François Bertucci, Antoine Italiano, Stéphanie Clisant, Nicolas Penel (2025). Corrigendum to “Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)”. , 36 (12), DOI: https://doi.org/10.1016/j.annonc.2025.07.011.
